Global Lice Treatment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product Type;

OTC Medication and Prescription Medication.

By Type;

Pediculosis Capitis, Pediculosis Corporis, Pediculosis Pubis, and Others.

By Route of Administration;

Oral, Topical, and Others.

By Distribution Channel;

Hospitals and Clinics, Retail Pharmacies, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn953186620 Published Date: March, 2025 Updated Date: April, 2025

Introduction

Global Lice Treatment Market (USD Million), 2021 - 2031

In the year 2023, the Global Lice Treatment Market was valued at USD 106.98 million. The size of this market is expected to increase to USD 173.48 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 7.2%.

Lice infestation, caused by parasitic insects known as lice, poses a common public health concern, particularly among school-age children and their families. The market for lice treatment encompasses a wide range of products and therapies aimed at eradicating lice infestations, relieving associated symptoms, and preventing reinfestation.

Key factors driving the growth of the Global Lice Treatment Market include the high prevalence of lice infestations in both developed and developing regions, fueled by factors such as close human contact, poor hygiene practices, and limited access to healthcare resources. Additionally, the increasing awareness about the social and psychological impact of lice infestations, including stigma, embarrassment, and discomfort, has underscored the need for effective and accessible treatment options.

In response to these challenges, the market has witnessed continuous innovation and development of lice treatment products, including over-the-counter (OTC) shampoos, lotions, and sprays containing pediculicides such as permethrin and pyrethrin. These products act by disrupting the nervous system of lice, leading to paralysis and eventual death. Furthermore, the emergence of resistance among lice populations to conventional pediculicides has spurred research and development efforts to identify alternative treatment modalities, including novel compounds, mechanical devices, and natural remedies.

The market landscape also includes prescription medications, such as oral or topical formulations containing insecticides or neurotoxic agents, which may be recommended for severe or treatment-resistant cases of lice infestation. Additionally, complementary therapies and preventive measures, such as nit combing, essential oils, and environmental decontamination, play a role in comprehensive lice management strategies.

Geographically, the Global Lice Treatment Market exhibits variations in lice prevalence rates, treatment preferences, and regulatory environments. North America and Europe represent significant markets, driven by high awareness levels, strong healthcare infrastructure, and stringent regulatory standards governing lice treatment products. Meanwhile, regions such as Asia-Pacific, Latin America, and the Middle East & Africa present opportunities for market expansion, propelled by rising healthcare expenditure, increasing consumer awareness, and growing demand for effective lice treatment solutions.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Type
    3. Market Snapshot, By Route of Administration
    4. Market Snapshot, By Distribution Channel
    5. Market Snapshot, By Region
  4. Global Lice Treatment Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Lice Infestation Prevalence

        2. Increasing Awareness

        3. Product Innovation

      2. Restraints
        1. Resistance to Treatments

        2. Regulatory Constraints

        3. Stigma and Embarrassment

      3. Opportunities
        1. Emerging Markets Expansion

        2. Alternative Treatment Modalities

        3. Collaborative Research Initiatives

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Lice Treatment Market, By Product Type, 2021 - 2031 (USD Million)
      1. OTC Medication
      2. Prescription Medication
    2. Global Lice Treatment Market, By Type, 2021 - 2031 (USD Million)
      1. Pediculosis Capitis
      2. Pediculosis Corporis
      3. Pediculosis Pubis
      4. Others
    3. Global Lice Treatment Market, By Route of Administration, 2021 - 2031 (USD Million)
      1. Oral
      2. Topical
      3. Others
    4. Global Lice Treatment Market, By Distribution Channel, 2021 - 2031 (USD Million)
      1. Hospitals and Clinics
      2. Retail Pharmacies
      3. Others
    5. Global Lice Treatment Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Alliance Pharmaceuticals Ltd.
      2. Prestige Consumer Healthcare Inc.
      3. GlaxoSmithKline plc
      4. Oystershell Consumer Health, Inc.
      5. Perrigo Company plc
  7. Analyst Views
  8. Future Outlook of the Market